99 related articles for article (PubMed ID: 27605588)
1. Distance to health services modifies the effect of an 11-valent pneumococcal vaccine on pneumonia risk among children less than 2 years of age in Bohol, Philippines.
Root ED; Lucero M; Nohynek H; Stubbs R; Tallo V; Lupisan SP; Sanvictores DM; Nillos LT; Simões EA;
Int J Epidemiol; 2017 Apr; 46(2):706-716. PubMed ID: 27605588
[TBL] [Abstract][Full Text] [Related]
2. Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.
Root ED; Lucero M; Nohynek H; Anthamatten P; Thomas DS; Tallo V; Tanskanen A; Quiambao BP; Puumalainen T; Lupisan SP; Ruutu P; Ladesma E; Williams GM; Riley I; Simões EA
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3520-5. PubMed ID: 24550454
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
[TBL] [Abstract][Full Text] [Related]
4. Radiology quality assurance in a developing country setting: the 11-valent pneumococcal conjugate vaccine trial, Bohol, Philippines.
Arcay JD; Ocampo AF; Solis RK; Oncog IB; Diaz AD; Epe AC; Cagadas R; Pabatang S; Ostensen H; Lucero MG;
Vaccine; 2007 Mar; 25(13):2528-32. PubMed ID: 17023097
[TBL] [Abstract][Full Text] [Related]
5. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.
Ortqvist A; Hedlund J; Burman LA; Elbel E; Höfer M; Leinonen M; Lindblad I; Sundelöf B; Kalin M
Lancet; 1998 Feb; 351(9100):399-403. PubMed ID: 9482293
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
[TBL] [Abstract][Full Text] [Related]
7. The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.
Izumi Y; Akazawa M; Akeda Y; Tohma S; Hirano F; Ideguchi H; Matsumura R; Miyamura T; Mori S; Fukui T; Iwanaga N; Jiuchi Y; Kozuru H; Tsutani H; Saisyo K; Sugiyama T; Suenaga Y; Okada Y; Katayama M; Ichikawa K; Furukawa H; Kawakami K; Oishi K; Migita K
Arthritis Res Ther; 2017 Jan; 19(1):15. PubMed ID: 28122642
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects.
Vila-Córcoles A; Ochoa-Gondar O; Llor C; Hospital I; Rodríguez T; Gómez A
Eur Respir J; 2005 Dec; 26(6):1086-91. PubMed ID: 16319340
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
10. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
[TBL] [Abstract][Full Text] [Related]
12. Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: a randomized, double-blind, placebo-controlled trial.
Russell KL; Baker CI; Hansen C; Poland GA; Ryan MA; Merrill MM; Gray GC
Vaccine; 2015 Feb; 33(9):1182-7. PubMed ID: 25579777
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
14. Radiographic pneumonia in young, highly febrile children with leukocytosis before and after universal conjugate pneumococcal vaccination.
Rutman MS; Bachur R; Harper MB
Pediatr Emerg Care; 2009 Jan; 25(1):1-7. PubMed ID: 19116501
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal conjugate vaccine--a health priority.
Zar HJ; Madhi SA
S Afr Med J; 2008 Jun; 98(6):463-7. PubMed ID: 18683380
[TBL] [Abstract][Full Text] [Related]
16. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.
Palmu AA; Rinta-Kokko H; Nohynek H; Nuorti JP; Kilpi TM; Jokinen J
PLoS One; 2017; 12(3):e0172690. PubMed ID: 28249015
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs.
Hansen J; Black S; Shinefield H; Cherian T; Benson J; Fireman B; Lewis E; Ray P; Lee J
Pediatr Infect Dis J; 2006 Sep; 25(9):779-81. PubMed ID: 16940833
[TBL] [Abstract][Full Text] [Related]
18. Reactogenicity and tolerability of a non-adjuvanted 11-valent diphtheria-tetanus toxoid pneumococcal conjugate vaccine in Filipino children.
Ugpo J; Lucero M; Williams G; Lechago M; Nillos L; Tallo V; Nohynek H;
Vaccine; 2009 May; 27(20):2723-9. PubMed ID: 18977267
[TBL] [Abstract][Full Text] [Related]
19. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.
Madhi SA; Kuwanda L; Cutland C; Klugman KP
Clin Infect Dis; 2005 May; 40(10):1511-8. PubMed ID: 15844075
[TBL] [Abstract][Full Text] [Related]
20. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
